Loading…
Indirect modulation of neuronal excitability and synaptic transmission in the hippocampus by activation of proteinase‐activated receptor‐2
BACKGROUND AND PURPOSE Proteinase‐activated receptor‐2 (PAR2) is widely expressed in the CNS under normal physiological conditions. However, its potential role in modulating neuronal excitability and synaptic transmission remains to be determined. Here, we have investigated whether PAR2 activation m...
Saved in:
Published in: | British journal of pharmacology 2011-07, Vol.163 (5), p.984-994 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c5643-37b5a088736c35815e5225b2dfaeba3175957ff9df5b4bf6d26e61f828cac6773 |
---|---|
cites | cdi_FETCH-LOGICAL-c5643-37b5a088736c35815e5225b2dfaeba3175957ff9df5b4bf6d26e61f828cac6773 |
container_end_page | 994 |
container_issue | 5 |
container_start_page | 984 |
container_title | British journal of pharmacology |
container_volume | 163 |
creator | Gan, J Greenwood, SM Cobb, SR Bushell, TJ |
description | BACKGROUND AND PURPOSE Proteinase‐activated receptor‐2 (PAR2) is widely expressed in the CNS under normal physiological conditions. However, its potential role in modulating neuronal excitability and synaptic transmission remains to be determined. Here, we have investigated whether PAR2 activation modulates synaptic activity in the hippocampus.
EXPERIMENTAL APPROACH PAR2 activation and its effect on the hippocampus were examined in rat primary cultures and acute slices using whole cell patch clamp and standard extracellular recordings, respectively.
KEY RESULTS PAR2 activation leads to a depolarization of hippocampal neurones and a paradoxical reduction in the occurrence of synaptically driven spontaneous action potentials (APs). PAR2‐induced neuronal depolarization was abolished following either the inhibition of astrocytic function or antagonism of ionotropic glutamate receptors whilst the PAR2‐induced decrease in AP frequency was also reduced when astrocytic function was inhibited. Furthermore, when examined in acute hippocampal slices, PAR2 activation induced a profound long‐term depression of synaptic transmission that was dependent on NMDA receptor activation and was sensitive to disruption of astrocytic function.
CONCLUSIONS AND IMPLICATIONS These novel findings show that PAR2 activation indirectly inhibits hippocampal synaptic activity and indicate that these receptors may play an active role in modulating normal physiological CNS function, in addition to their role in pathophysiological disorders. |
doi_str_mv | 10.1111/j.1476-5381.2011.01293.x |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3130945</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>880134227</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5643-37b5a088736c35815e5225b2dfaeba3175957ff9df5b4bf6d26e61f828cac6773</originalsourceid><addsrcrecordid>eNqNkstu1DAUhiMEokPhFZAlhGCT4GvsLECiFdBKlWABa8txHMajxA62U2Z2fQLEM_IkOMwwXBYIe2HL5zs3n78oAIIVyuvZpkKU1yUjAlUYIlRBhBtSbW8Vq6PhdrGCEPISISFOinsxbiDMRs7uFicYkbpmjKyKL5eus8HoBEbfzYNK1jvge-DMHLxTAzBbbZNq7WDTDijXgbhzakpWgxSUi6ONcXGxDqS1AWs7TV6rcZojaDOvk70-xpyCT8Y6Fc23m68Hk-lAzm6m5EN-xPeLO70aonlwOE-LD69fvT-_KK_evrk8f3lValZTUhLeMgWF4KTWhAnEDMOYtbjrlWkVQZw1jPd90_WspW1fd7g2NeoFFlrpmnNyWrzYx53mdjSdNi53M8gp2FGFnfTKyj8tzq7lR38tCSKwoSwHeHIIEPyn2cQk809oMwzKGT9HKQREhGK8pHr6TzKPglOBMSQZffQXuvFzyFPIFKOMU04anCmxp3TwMQbTH8tGUC7ykBu5qEAuKpCLPOQPechtdn34e9tHx596yMDjA6CiVkOfR6xt_MXRvBtOM_d8z322g9n9dwHy7N3FciPfAYQL24g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1545747392</pqid></control><display><type>article</type><title>Indirect modulation of neuronal excitability and synaptic transmission in the hippocampus by activation of proteinase‐activated receptor‐2</title><source>PubMed Central Free</source><source>Wiley-Blackwell Read & Publish Collection</source><creator>Gan, J ; Greenwood, SM ; Cobb, SR ; Bushell, TJ</creator><creatorcontrib>Gan, J ; Greenwood, SM ; Cobb, SR ; Bushell, TJ</creatorcontrib><description>BACKGROUND AND PURPOSE Proteinase‐activated receptor‐2 (PAR2) is widely expressed in the CNS under normal physiological conditions. However, its potential role in modulating neuronal excitability and synaptic transmission remains to be determined. Here, we have investigated whether PAR2 activation modulates synaptic activity in the hippocampus.
EXPERIMENTAL APPROACH PAR2 activation and its effect on the hippocampus were examined in rat primary cultures and acute slices using whole cell patch clamp and standard extracellular recordings, respectively.
KEY RESULTS PAR2 activation leads to a depolarization of hippocampal neurones and a paradoxical reduction in the occurrence of synaptically driven spontaneous action potentials (APs). PAR2‐induced neuronal depolarization was abolished following either the inhibition of astrocytic function or antagonism of ionotropic glutamate receptors whilst the PAR2‐induced decrease in AP frequency was also reduced when astrocytic function was inhibited. Furthermore, when examined in acute hippocampal slices, PAR2 activation induced a profound long‐term depression of synaptic transmission that was dependent on NMDA receptor activation and was sensitive to disruption of astrocytic function.
CONCLUSIONS AND IMPLICATIONS These novel findings show that PAR2 activation indirectly inhibits hippocampal synaptic activity and indicate that these receptors may play an active role in modulating normal physiological CNS function, in addition to their role in pathophysiological disorders.</description><identifier>ISSN: 0007-1188</identifier><identifier>ISSN: 1476-5381</identifier><identifier>EISSN: 1476-5381</identifier><identifier>DOI: 10.1111/j.1476-5381.2011.01293.x</identifier><identifier>PMID: 21366553</identifier><identifier>CODEN: BJPCBM</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Action Potentials - drug effects ; Action Potentials - physiology ; Animals ; Animals, Newborn ; astrocyte ; Astrocytes - drug effects ; Astrocytes - metabolism ; Astrocytes - physiology ; Biological and medical sciences ; Dose-Response Relationship, Drug ; hippocampus ; Hippocampus - drug effects ; Hippocampus - metabolism ; Hippocampus - physiology ; In Vitro Techniques ; Medical sciences ; Muscular system ; neuronal excitability ; Neurons - drug effects ; Neurons - metabolism ; Neurons - physiology ; NMDA ; Oligopeptides - pharmacology ; Patch-Clamp Techniques ; Pharmacology. Drug treatments ; proteinase‐activated receptor‐2 ; Rats ; Rats, Sprague-Dawley ; Rats, Wistar ; Receptor, PAR-2 - agonists ; Receptor, PAR-2 - physiology ; Research Papers ; Rodents ; synaptic transmission ; Synaptic Transmission - drug effects ; Synaptic Transmission - physiology</subject><ispartof>British journal of pharmacology, 2011-07, Vol.163 (5), p.984-994</ispartof><rights>2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society</rights><rights>2015 INIST-CNRS</rights><rights>2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society.</rights><rights>British Journal of Pharmacology © 2011 The British Pharmacological Society 2011</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5643-37b5a088736c35815e5225b2dfaeba3175957ff9df5b4bf6d26e61f828cac6773</citedby><cites>FETCH-LOGICAL-c5643-37b5a088736c35815e5225b2dfaeba3175957ff9df5b4bf6d26e61f828cac6773</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3130945/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3130945/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24242974$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21366553$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gan, J</creatorcontrib><creatorcontrib>Greenwood, SM</creatorcontrib><creatorcontrib>Cobb, SR</creatorcontrib><creatorcontrib>Bushell, TJ</creatorcontrib><title>Indirect modulation of neuronal excitability and synaptic transmission in the hippocampus by activation of proteinase‐activated receptor‐2</title><title>British journal of pharmacology</title><addtitle>Br J Pharmacol</addtitle><description>BACKGROUND AND PURPOSE Proteinase‐activated receptor‐2 (PAR2) is widely expressed in the CNS under normal physiological conditions. However, its potential role in modulating neuronal excitability and synaptic transmission remains to be determined. Here, we have investigated whether PAR2 activation modulates synaptic activity in the hippocampus.
EXPERIMENTAL APPROACH PAR2 activation and its effect on the hippocampus were examined in rat primary cultures and acute slices using whole cell patch clamp and standard extracellular recordings, respectively.
KEY RESULTS PAR2 activation leads to a depolarization of hippocampal neurones and a paradoxical reduction in the occurrence of synaptically driven spontaneous action potentials (APs). PAR2‐induced neuronal depolarization was abolished following either the inhibition of astrocytic function or antagonism of ionotropic glutamate receptors whilst the PAR2‐induced decrease in AP frequency was also reduced when astrocytic function was inhibited. Furthermore, when examined in acute hippocampal slices, PAR2 activation induced a profound long‐term depression of synaptic transmission that was dependent on NMDA receptor activation and was sensitive to disruption of astrocytic function.
CONCLUSIONS AND IMPLICATIONS These novel findings show that PAR2 activation indirectly inhibits hippocampal synaptic activity and indicate that these receptors may play an active role in modulating normal physiological CNS function, in addition to their role in pathophysiological disorders.</description><subject>Action Potentials - drug effects</subject><subject>Action Potentials - physiology</subject><subject>Animals</subject><subject>Animals, Newborn</subject><subject>astrocyte</subject><subject>Astrocytes - drug effects</subject><subject>Astrocytes - metabolism</subject><subject>Astrocytes - physiology</subject><subject>Biological and medical sciences</subject><subject>Dose-Response Relationship, Drug</subject><subject>hippocampus</subject><subject>Hippocampus - drug effects</subject><subject>Hippocampus - metabolism</subject><subject>Hippocampus - physiology</subject><subject>In Vitro Techniques</subject><subject>Medical sciences</subject><subject>Muscular system</subject><subject>neuronal excitability</subject><subject>Neurons - drug effects</subject><subject>Neurons - metabolism</subject><subject>Neurons - physiology</subject><subject>NMDA</subject><subject>Oligopeptides - pharmacology</subject><subject>Patch-Clamp Techniques</subject><subject>Pharmacology. Drug treatments</subject><subject>proteinase‐activated receptor‐2</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Rats, Wistar</subject><subject>Receptor, PAR-2 - agonists</subject><subject>Receptor, PAR-2 - physiology</subject><subject>Research Papers</subject><subject>Rodents</subject><subject>synaptic transmission</subject><subject>Synaptic Transmission - drug effects</subject><subject>Synaptic Transmission - physiology</subject><issn>0007-1188</issn><issn>1476-5381</issn><issn>1476-5381</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNqNkstu1DAUhiMEokPhFZAlhGCT4GvsLECiFdBKlWABa8txHMajxA62U2Z2fQLEM_IkOMwwXBYIe2HL5zs3n78oAIIVyuvZpkKU1yUjAlUYIlRBhBtSbW8Vq6PhdrGCEPISISFOinsxbiDMRs7uFicYkbpmjKyKL5eus8HoBEbfzYNK1jvge-DMHLxTAzBbbZNq7WDTDijXgbhzakpWgxSUi6ONcXGxDqS1AWs7TV6rcZojaDOvk70-xpyCT8Y6Fc23m68Hk-lAzm6m5EN-xPeLO70aonlwOE-LD69fvT-_KK_evrk8f3lValZTUhLeMgWF4KTWhAnEDMOYtbjrlWkVQZw1jPd90_WspW1fd7g2NeoFFlrpmnNyWrzYx53mdjSdNi53M8gp2FGFnfTKyj8tzq7lR38tCSKwoSwHeHIIEPyn2cQk809oMwzKGT9HKQREhGK8pHr6TzKPglOBMSQZffQXuvFzyFPIFKOMU04anCmxp3TwMQbTH8tGUC7ykBu5qEAuKpCLPOQPechtdn34e9tHx596yMDjA6CiVkOfR6xt_MXRvBtOM_d8z322g9n9dwHy7N3FciPfAYQL24g</recordid><startdate>201107</startdate><enddate>201107</enddate><creator>Gan, J</creator><creator>Greenwood, SM</creator><creator>Cobb, SR</creator><creator>Bushell, TJ</creator><general>Blackwell Publishing Ltd</general><general>Nature Publishing Group</general><general>Blackwell Science Inc</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TK</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201107</creationdate><title>Indirect modulation of neuronal excitability and synaptic transmission in the hippocampus by activation of proteinase‐activated receptor‐2</title><author>Gan, J ; Greenwood, SM ; Cobb, SR ; Bushell, TJ</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5643-37b5a088736c35815e5225b2dfaeba3175957ff9df5b4bf6d26e61f828cac6773</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Action Potentials - drug effects</topic><topic>Action Potentials - physiology</topic><topic>Animals</topic><topic>Animals, Newborn</topic><topic>astrocyte</topic><topic>Astrocytes - drug effects</topic><topic>Astrocytes - metabolism</topic><topic>Astrocytes - physiology</topic><topic>Biological and medical sciences</topic><topic>Dose-Response Relationship, Drug</topic><topic>hippocampus</topic><topic>Hippocampus - drug effects</topic><topic>Hippocampus - metabolism</topic><topic>Hippocampus - physiology</topic><topic>In Vitro Techniques</topic><topic>Medical sciences</topic><topic>Muscular system</topic><topic>neuronal excitability</topic><topic>Neurons - drug effects</topic><topic>Neurons - metabolism</topic><topic>Neurons - physiology</topic><topic>NMDA</topic><topic>Oligopeptides - pharmacology</topic><topic>Patch-Clamp Techniques</topic><topic>Pharmacology. Drug treatments</topic><topic>proteinase‐activated receptor‐2</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Rats, Wistar</topic><topic>Receptor, PAR-2 - agonists</topic><topic>Receptor, PAR-2 - physiology</topic><topic>Research Papers</topic><topic>Rodents</topic><topic>synaptic transmission</topic><topic>Synaptic Transmission - drug effects</topic><topic>Synaptic Transmission - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gan, J</creatorcontrib><creatorcontrib>Greenwood, SM</creatorcontrib><creatorcontrib>Cobb, SR</creatorcontrib><creatorcontrib>Bushell, TJ</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gan, J</au><au>Greenwood, SM</au><au>Cobb, SR</au><au>Bushell, TJ</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Indirect modulation of neuronal excitability and synaptic transmission in the hippocampus by activation of proteinase‐activated receptor‐2</atitle><jtitle>British journal of pharmacology</jtitle><addtitle>Br J Pharmacol</addtitle><date>2011-07</date><risdate>2011</risdate><volume>163</volume><issue>5</issue><spage>984</spage><epage>994</epage><pages>984-994</pages><issn>0007-1188</issn><issn>1476-5381</issn><eissn>1476-5381</eissn><coden>BJPCBM</coden><abstract>BACKGROUND AND PURPOSE Proteinase‐activated receptor‐2 (PAR2) is widely expressed in the CNS under normal physiological conditions. However, its potential role in modulating neuronal excitability and synaptic transmission remains to be determined. Here, we have investigated whether PAR2 activation modulates synaptic activity in the hippocampus.
EXPERIMENTAL APPROACH PAR2 activation and its effect on the hippocampus were examined in rat primary cultures and acute slices using whole cell patch clamp and standard extracellular recordings, respectively.
KEY RESULTS PAR2 activation leads to a depolarization of hippocampal neurones and a paradoxical reduction in the occurrence of synaptically driven spontaneous action potentials (APs). PAR2‐induced neuronal depolarization was abolished following either the inhibition of astrocytic function or antagonism of ionotropic glutamate receptors whilst the PAR2‐induced decrease in AP frequency was also reduced when astrocytic function was inhibited. Furthermore, when examined in acute hippocampal slices, PAR2 activation induced a profound long‐term depression of synaptic transmission that was dependent on NMDA receptor activation and was sensitive to disruption of astrocytic function.
CONCLUSIONS AND IMPLICATIONS These novel findings show that PAR2 activation indirectly inhibits hippocampal synaptic activity and indicate that these receptors may play an active role in modulating normal physiological CNS function, in addition to their role in pathophysiological disorders.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>21366553</pmid><doi>10.1111/j.1476-5381.2011.01293.x</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0007-1188 |
ispartof | British journal of pharmacology, 2011-07, Vol.163 (5), p.984-994 |
issn | 0007-1188 1476-5381 1476-5381 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3130945 |
source | PubMed Central Free; Wiley-Blackwell Read & Publish Collection |
subjects | Action Potentials - drug effects Action Potentials - physiology Animals Animals, Newborn astrocyte Astrocytes - drug effects Astrocytes - metabolism Astrocytes - physiology Biological and medical sciences Dose-Response Relationship, Drug hippocampus Hippocampus - drug effects Hippocampus - metabolism Hippocampus - physiology In Vitro Techniques Medical sciences Muscular system neuronal excitability Neurons - drug effects Neurons - metabolism Neurons - physiology NMDA Oligopeptides - pharmacology Patch-Clamp Techniques Pharmacology. Drug treatments proteinase‐activated receptor‐2 Rats Rats, Sprague-Dawley Rats, Wistar Receptor, PAR-2 - agonists Receptor, PAR-2 - physiology Research Papers Rodents synaptic transmission Synaptic Transmission - drug effects Synaptic Transmission - physiology |
title | Indirect modulation of neuronal excitability and synaptic transmission in the hippocampus by activation of proteinase‐activated receptor‐2 |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T15%3A42%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Indirect%20modulation%20of%20neuronal%20excitability%20and%20synaptic%20transmission%20in%20the%20hippocampus%20by%20activation%20of%20proteinase%E2%80%90activated%20receptor%E2%80%902&rft.jtitle=British%20journal%20of%20pharmacology&rft.au=Gan,%20J&rft.date=2011-07&rft.volume=163&rft.issue=5&rft.spage=984&rft.epage=994&rft.pages=984-994&rft.issn=0007-1188&rft.eissn=1476-5381&rft.coden=BJPCBM&rft_id=info:doi/10.1111/j.1476-5381.2011.01293.x&rft_dat=%3Cproquest_pubme%3E880134227%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5643-37b5a088736c35815e5225b2dfaeba3175957ff9df5b4bf6d26e61f828cac6773%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1545747392&rft_id=info:pmid/21366553&rfr_iscdi=true |